Personalized Medicine: Changing the Face of Healthcare?
During this breakfast discussion panel, three Bay Area senior executives will share their insights on the meaning and the future of the personalized medicine revolution.
29 Sep 2005 from 6:30 AM to 8:30 AM Pacific Time
|
|
|
|
|
Practical Information:
Location:
730 Montgomery Street, San Francisco CA 94111
Cost:
Free event
New understandings of disease diagnostics and treatment have fueled predictions of a transition from "sick-care" to more integrative health care systems. Recent withdrawals of blockbuster drugs Vioxx and Tysabri due to safety concerns highlight the dangers of a "one size fits all" drug development model. Taking the opposite approach, personalized medicine seeks to create differentiated strategies for the prevention and care of disease through the use of 'tailored' medications. Drawing from the convergence of pharmacogenomics and proteomics, personalized medicine promises to make the drug development process faster, cheaper and more effective while also improving drug safety. However, this paradigm shift also poses important ethical challenges (such as the need to balance commercial and public health priorities) that will need to be carefully addressed. During our breakfast discussion panel, three Bay Area senior executives will share their insights on the meaning and the future of the personalized medicine revolution, to which they have directly contributed as important actors within each of their respective companies.
Program: 7:30 to 8:00 light breakfast & networking 8:00 to 8:45 10 min talks by each of the 3 panelists
|
In partnership with FACCSF - French-American Chamber of Commerce, San Francisco Chapter BayBio - Northern California's Life Science Association IMBS - Institute of Biomedical Science qb3 - California Institute for Quantitative Biomedical Research |
